A Randomized, Double-Blind, Placebo-Controlled Trial of the Safety and Efficacy of Topical Alicaforsen Enema in Subjects With Active, Chronic, Antibiotic Refractory Primary Idiopathic Pouchitis
Phase of Trial: Phase III
Latest Information Update: 12 Sep 2017
At a glance
- Drugs Alicaforsen (Primary)
- Indications Pouchitis
- Focus Registrational; Therapeutic Use
- Sponsors Atlantic Pharmaceuticals
- 12 Sep 2017 According to an Atlantic Healthcare media release, 110th patient has been recruited.
- 08 Mar 2017 Planned primary completion date changed from 1 Jan 2017 to 15 Sep 2017.
- 08 Mar 2017 Planned end date changed from 1 Apr 2017 to 18 Jan 2018.